Overview

Phase I Chinese PK

Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
An open, phase 1 to assess the PK of rising doses of ZD6474 when administered daily in Chinese patients with advanced solid malignant tumors.
Phase:
Phase 1
Details
Lead Sponsor:
Genzyme, a Sanofi Company